Overland Pharma is a newly founded biopharma company wholly owned by Hillhouse Capital, a leading Asia-focused global investment fund. Our vision is to become a game changer in bringing innovative and important medicines to underserved patients in Asia. We are establishing a pipeline of innovative programs through business development and partnering efforts in a few carefully selected therapeutic areas, fully leveraging Hillhouse’s unparalleled biopharma ecosystem and long-term capital.